B-CELL MEDIATED AUTOIMMUNE DISORDERS
Clinical trials for B-CELL MEDIATED AUTOIMMUNE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new B-CELL MEDIATED AUTOIMMUNE DISORDERS trials appear
Sign up with your email to follow new studies for B-CELL MEDIATED AUTOIMMUNE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target Hard-to-Treat IgG4 disease
Disease control Recruiting nowThis study tests a new treatment called anti-BCMA-CD19 CAR-T cells for adults with IgG4-related disease that hasn't improved with standard therapies. The treatment involves collecting a patient's own immune cells, modifying them to target the disease, and infusing them back. Rese…
Matched conditions: B-CELL MEDIATED AUTOIMMUNE DISORDERS
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 25, 2026 15:04 UTC
-
Could CAR t-cells tame autoimmune disease? new trial launches.
Disease control Recruiting nowThis early-phase study tests a new treatment called azercabtagene zapreleucel (azer-cel) for people with B-cell mediated autoimmune disorders like multiple sclerosis. About 100 adults will receive this cell therapy to find the safest dose and see if it can control disease activit…
Matched conditions: B-CELL MEDIATED AUTOIMMUNE DISORDERS
Phase: PHASE1 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC